MktsMarkets

Bicycle Therapeutics plc
NASDAQ: BCYCKey statistics
BCYC News
Stories mentioning BCYC from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 887.00 | 47,955 | 11,734 | 2,920 | 9,977 | 3,708 | 2,676 | 9,361 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 48,901 | 51,770 | 58,426 | 71,029 | 59,058 | 49,778 | 48,265 | 40,059 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 66,369 | 72,663 | 77,285 | 89,522 | 80,181 | 71,371 | 66,522 | 56,008 |
| Operating Income (Loss) | (65,482) | (24,708) | (65,551) | (86,602) | (70,204) | (67,663) | (63,846) | (46,647) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (60,653) | (18,889) | (58,895) | (79,183) | (61,841) | (52,936) | (54,250) | (39,697) |
| Tax Provision | 172.00 | 1,265 | 205.00 | (231.00) | (1,087) | (1,082) | (3,448) | 115.00 |
| Net Income (Loss) | (60,825) | (20,154) | (59,100) | (78,952) | (60,754) | (51,854) | (50,802) | (39,812) |
| Earnings Per Share (Basic) | (0.87) | (0.29) | (0.85) | (1.14) | (0.88) | (0.89) | (0.74) | (0.77) |
| Earnings Per Share (Diluted) | (0.87) | (0.29) | (0.85) | (1.14) | (0.88) | (0.89) | (0.74) | (0.77) |
| Weighted Average Shares Outstanding (Basic) | 69,683 | 69,280 | 69,304 | 69,252 | 69,197 | 58,208 | 68,989 | 51,992 |
| Weighted Average Shares Outstanding (Diluted) | 69,683 | 69,280 | 69,304 | 69,252 | 69,197 | 58,208 | 68,989 | 51,992 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BCYC
Bicycle Therapeutics plc (NASDAQ: BCYC) is a stock listed on the Nasdaq Stock Market under the ticker symbol BCYC. It last traded at $3.05 (Nov 19, 2026, 4:00 PM ET), down 1.9% on the day. That gives Bicycle Therapeutics a market capitalisation of $217.7M.
Over the past 52 weeks BCYC has traded between $3.07 and $7.83.
Revenue for the quarter ended Mar 31, 2026 was $887.0K; a net loss of $60.8M. Revenue was down 91.1% from $10.0M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $887.0K | -$60.8M | -6857.4% |
| Dec 31, 2025 | $48.0M | -$20.2M | -42.0% |
| Sep 30, 2025 | $11.7M | -$59.1M | -503.7% |
| Jun 30, 2025 | $2.9M | -$79.0M | -2703.8% |
From Bicycle Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…